Resmed Inc. buy UBS Group AG
Start price
12.12.25
/
50%
€214.10
Target price
12.12.26
-
Performance (%)
-16.23%
Price
20:21
€179.35
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -16.23%. This prediction currently runs until 12.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 7.131% | 7.131% |
| iShares Core DAX® | 1,84 % | 1,39 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % |
| iShares S&P 500 | 3,70 % | 1,58 % |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RMD provided by MarketBeat